Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
Kidney International Reports|April 20, 2026
Systematic Review of Trial Design and End Points in Lupus NephritisSophia Giang, Maria A Dall'Era, Rachel B Jones, et al.
Lupus Science & Medicine|May 31, 2023
Remission of lupus nephritis: the trajectory of histological response in successfully treated patientsAna Malvar, Valeria Alberton, Bruno Lococo, et al.
Frontiers in Nutrition|January 24, 2022
Traditional Foods From Maize (<i>Zea mays</i> L.) in EuropePedro Revilla, Mara Lisa Alves, Violeta Andelković, et al.
Kidney International|April 29, 2026
Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritisBrad H Rovin, Richard Furie, Ana Malvar, et al.
Kidney International|September 24, 2021
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritisBrad H Rovin, Richard Furie, Y K Onno Teng, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 18, 2023
Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trialHans-Joachim Anders, Richard Furie, Ana Malvar, et al.
Annals of the Rheumatic Diseases|October 7, 2021
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trialRichard A Furie, Gustavo Aroca, Matthew D Cascino, et al.
Journal of Clinical Medicine|September 25, 2019
Rethinking Lupus Nephritis Classification on a Molecular LevelSalem Almaani, Stephenie D Prokopec, Jianying Zhang, et al.
Autoimmunity Reviews|April 3, 2025
Lupus nephritis trials network (LNTN) repeat kidney biopsy-based definitions of treatment response: A systematic literature review-based proposalIoannis Parodis, Nursen Cetrez, Leonardo Palazzo, et al.
Pageof 7